HLA-ABC anticorps (PE)
-
- Antigène Voir toutes HLA-ABC Anticorps
- HLA-ABC
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp HLA-ABC est conjugé à/à la PE
-
Application
- Flow Cytometry (FACS)
- Fonction
- Mouse monoclonal antibody raised against native HLA-Class I.
- Specificité
- This antibody reacts with all human classical MHC Class I molecules in native cell-surface forms (e.g. it recognizes native HLA-A2 in cytofluorometry and immunoprecipitation but not in Western blot). This antibody is positive in Western blot (non-reducing conditions) only with most HLA-B and HLA-C molecules, but not HLA-A.
- Immunogène
- Native purified HLA-Class I from PHA-activated peripheral blood lymphocytes.
- Clone
- MEM-147
- Isotype
- IgG1
- Top Product
- Discover our top product HLA-ABC Anticorps primaire
-
-
- Indications d'application
-
Flow Cytometry (5 μg/mL)
The optimal working dilution should be determined by the end user. - Restrictions
- For Research Use only
-
- Concentration
- 0.1 mg/mL
- Buffer
- In PBS (0.2 % BSA, 0.09 % sodium azide)
- Stock
- 4 °C
- Stockage commentaire
-
Store in the dark at 4°C. Do not freeze.
Avoid prolonged exposure to light.
Aliquot to avoid repeated freezing and thawing.
-
-
Expression of HLA-G in human cornea, an immune-privileged tissue." dans: Human immunology, Vol. 64, Issue 11, pp. 1039-44, (2003) (PubMed).
: "The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complex." dans: Immunogenetics, Vol. 53, Issue 6, pp. 440-6, (2001) (PubMed).
: "
-
Expression of HLA-G in human cornea, an immune-privileged tissue." dans: Human immunology, Vol. 64, Issue 11, pp. 1039-44, (2003) (PubMed).
-
- Antigène
- HLA-ABC
- Autre désignation
- HLA Class I ABC (HLA-ABC Produits)
- Synonymes
- anticorps HLAA, anticorps major histocompatibility complex, class I, A, anticorps HLA-A
- Pathways
- TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-